Stellate Ganglion Block Combined With Subanesthetic Ketamine Versus Dexmedetomidine for the Management of Paroxysmal Sympathetic Hyperactivity (PSH) After Traumatic Brain Injury: A Randomized Trial
Critical Care Research and Practice · 2026-01 · 2026 (1)
DOI: 10.1155/ccrp/2779975 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Critical Care Research and Practice, online erschienen am 04.11.2026. Verfasst von Eslam Sobhy Al Maghawry Mohamed und 7 weiteren Autor:innen. Beteiligte Einrichtung: Anesthesia Intensive Care and Pain Management Department Faculty of Medicine Zagazig University Alsharkia Egypt zu.edu.eg. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
With appropriate treatment of paroxysmal sympathetic hyperactivity (PSH) following a traumatic brain injury, there is hope for individuals to overcome storming, regain consciousness, and progress toward successful recovery from the brain injury. The primary goal was to monitor changes in mean arterial blood pressure (MABP) in TBI patients with PSH treated with stellate ganglion block combined with subanesthetic dose ketamine versus dexmedetomidine infusion. The secondary outcomes included monitoring changes in heart rate, respiratory rate, temperature decline, duration of the resolution of paroxysmal hypermyotonia, Glasgow Coma Scale (GCS) grading, intensive care unit (ICU) stay, and the number of patients who did not show improvement.
Methods
This randomized, double‐blind controlled study was conducted on 102 patients with traumatic brain injury experiencing PSH. They were randomly allocated into two groups: the SK group ( n = 51), where patients received a unilateral stellate ganglion block with 5 mL of bupivacaine 0.5% combined with 0.5 mg/kg/h intravenous subanesthetic ketamine infusion, and the D group ( n = 51), where patients received a loading dose of 1 μg/kg dexmedetomidine for 10 min and then starting an intravenous infusion at a rate of 1 μg/kg/h.
Results
The D group exhibited a significant earlier decrease in MABP compared to the SK group at 30 min, 1, 2, 4, 8, 16, 24, and 48 h ( p value = 0.0001). Both groups experienced similar reductions in RR at the same time points ( p values ≥ 0.5). The temperature decreased after approximately 10 h from initiating treatment with no significant difference between the two groups. Four patients in the D group and three patients in the SK group did not show significant improvement. In terms of GCS, patients in both groups demonstrated significant improvement in GCS grading (18 [35.3%] Grade I, 29 [56.9%] Grade II, and only 1 [2.0%] and 3 [5.9%] Grades III and IV, respectively, in the D group, and 20 [39.2%] Grade I, 28 [54.9%] Grade II, and only 2 [3.9%] Grade III and 1 [2.0%] Grade IV in the SK group) ( p = 0.0001). Both groups had similar durations of ICU stay ( p = 0.222).
Conclusions
A unilateral stellate ganglion block combined with subanesthetic ketamine improves overall neurological recovery and ICU length of stay in post‐TBI PSH compared to continuous dexmedetomidine. However, dexmedetomidine provides a faster reduction in MABP and offers high practical value due to its noninvasive, intravenous delivery. Trial Registration: ClinicalTrials.gov identifier: NCT06354673.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Anesthesia Intensive Care and Pain Management Department Faculty of Medicine Zagazig University Alsharkia Egypt zu.edu.eg.
- Faculty of Human Medicine Zagazig University Zagazig Alsharkia Egypt zu.edu.eg.
- Dubai Hospital Dubai UAE dha.gov.ae.
- Radiology Department Faculty of Medicine, Zagazig University Alsharkia Egypt.
ORCID-Profile: Eslam Sobhy Al Maghawry Mohamed, Alshaimaa Abdel Fattah Kamel, Mohamed Gaber Mohamed, Michael Adel Shaker, Omar A Khashaba, Marwa Mohamed Medhat
Zitieren
APA
Mohamed, E. S. A. M., Kamel, A. A. F., Mohamed, A. M. G., Elmesallamy, A. E. W. A. E. A., Mohamed, M. G., Shaker, M. A., Khashaba, O. A., & Medhat, M. M. (2026). Stellate Ganglion Block Combined With Subanesthetic Ketamine Versus Dexmedetomidine for the Management of Paroxysmal Sympathetic Hyperactivity (PSH) After Traumatic Brain Injury: A Randomized Trial. Critical Care Research and Practice, 2026(1). https://doi.org/10.1155/ccrp/2779975
Vancouver
Mohamed ESAM, Kamel AAF, Mohamed AMG, Elmesallamy AEWAEA, Mohamed MG, Shaker MA, et al. Stellate Ganglion Block Combined With Subanesthetic Ketamine Versus Dexmedetomidine for the Management of Paroxysmal Sympathetic Hyperactivity (PSH) After Traumatic Brain Injury: A Randomized Trial. Critical Care Research and Practice. 2026;2026(1). doi:10.1155/ccrp/2779975
BibTeX
@article{Mohamed2026,
author = {Mohamed, Eslam Sobhy Al Maghawry and Kamel, Alshaimaa Abdel Fattah and Mohamed, Abdalla Mohamed Goda and Elmesallamy, Abd El-Rahman Wael Abd El-Rahman Ali and Mohamed, Mohamed Gaber and Shaker, Michael Adel and Khashaba, Omar A and Medhat, Marwa Mohamed},
title = {Stellate Ganglion Block Combined With Subanesthetic Ketamine Versus Dexmedetomidine for the Management of Paroxysmal Sympathetic Hyperactivity (PSH) After Traumatic Brain Injury: A Randomized Trial},
journal = {Critical Care Research and Practice},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/ccrp/2779975}
}
EUVIMED